The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity (original) (raw)
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Julie Lotharius
Journal of Biological Chemistry, 2000
View PDFchevron_right
Lipophilic organic cations are novel environmental dopaminergic toxins that may contribute to the etiology of Parkinson's disease
CHAMILA KADIGAMUWA
2015
View PDFchevron_right
Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat
Shane Kruse
Proceedings of the National Academy of Sciences, 2008
View PDFchevron_right
Dopamine Selectively Sensitizes Dopaminergic Neurons to Rotenone-Induced Apoptosis
Ferogh Ahmadi
Neurochemical Research, 2007
View PDFchevron_right
Dopamine Oxidation Products as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson's Disease
Paolo Bernardi
ACS chemical neuroscience, 2018
View PDFchevron_right
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease
David Blum
2001
View PDFchevron_right
The Parkinsonian Neurotoxin 1-Methyl-4-Phenylpyridinium (MPP + ) Mediates Release of l -3,4-Dihydroxyphenylalanine ( l -DOPA) and Inhibition of l -DOPA Decarboxylase in the Rat Striatum: A Microdialysis Study
Glenn Dryhurst
Chemical Research in Toxicology, 2003
View PDFchevron_right
Dopaminergic Neurotoxicity In Vivo and Inhibition of Mitochondrial Respiration In Vitro by Possible Endogenous Pyridinium-Like Substances
Charles Hoppel
Journal of Neurochemistry, 1991
View PDFchevron_right
Mechanism of toxicity in rotenone models of Parkinson's disease
Jason Richardson
The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003
View PDFchevron_right
Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave …
Rebecca Angela
Journal of …
View PDFchevron_right
Lipophilic Cationic Cyanines Are Potent Complex I Inhibitors and Specific in Vitro Dopaminergic Toxins with Mechanistic Similarities to Both Rotenone and MPP
CHAMILA KADIGAMUWA
View PDFchevron_right
Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
Russell Swerdlow
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
View PDFchevron_right
Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease
Sasanka Chakrabarti
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
View PDFchevron_right
The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson's disease
Felipe Patricio Martinez
Neuroscience Research, 2021
View PDFchevron_right
Alterations in bioenergetic function induced by Parkinson’s disease mimetic compounds: lack of correlation with superoxide generation
Jacek Zielonka
Journal of Neurochemistry, 2012
View PDFchevron_right
Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium
Christian Pifl
The Journal of Neuroscience the Official Journal of the Society For Neuroscience, 1993
View PDFchevron_right
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine
Ritik Kumar
Life sciences, 1985
View PDFchevron_right
Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's …
Tanusree Sen
… et Biophysica Acta (BBA …, 2005
View PDFchevron_right
Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease
Masato Asanuma
Neurotoxicity Research, 2003
View PDFchevron_right
Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: Implications for Parkinson's disease
Sasanka Chakrabarti
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
View PDFchevron_right
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
Mesbah Alam
Behavioural Brain Research, 2002
View PDFchevron_right
Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse
Rita Perfeito
Free Radical Biology and Medicine, 2013
View PDFchevron_right
Toxin-induced models of Parkinson’s disease
Celine Perier
NeuroRX, 2005
View PDFchevron_right
Potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium: Selective toxicity of 1-methyl-4-(4′-acetamidophenyl)-pyridinium and 1-methyl-4-cyclohexylpyridinium for dopaminergic neurons in culture
Simon Efange
Experimental Neurology, 1990
View PDFchevron_right
Effect of Cynodon dactylon on rotenone induced Parkinson’s disease
neha sharma
Oriental Pharmacy and Experimental Medicine, 2012
View PDFchevron_right
Irreversible Inhibition of Mitochondrial Complex I by 7‐(2‐Aminoethyl)‐3,4‐Dihydro‐5‐Hydroxy‐2H‐1,4‐Benzothiazine‐3‐Carboxylic Acid (DHBT‐1): A Putative Nigral Endotoxin of Relevance to Parkinson's Disease
Glenn Dryhurst
Journal of Neurochemistry, 1997
View PDFchevron_right
Obligatory Role for Complex I Inhibition in the Dopaminergic Neurotoxicity of 1Methyl4-phenyl-1,2,3,6-tetrahydropyridine (MPTP
eiko nakamaru-ogiso
Toxicological Sciences, 2006
View PDFchevron_right
Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity
James Adams
Biochemical Pharmacology, 1991
View PDFchevron_right
Identification of the major transport pathway for the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium
Adil Shamoo
Neuroscience, 1996
View PDFchevron_right
Toxin-Induced Parkinson’s Disease Models
gokul krishna
Neuro – Open Journal, 2017
View PDFchevron_right
Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
Marco Bisaglia
Antioxidants
View PDFchevron_right
Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria
Rona Ramsay
Journal of Biological Chemistry, 1986
View PDFchevron_right